🚀 go-pugleaf

RetroBBS NetNews Server

Inspired by RockSolid Light RIP Retro Guy

Article View: be.science
Article #415

Cancer - Press Review (August 18, 2012) – Revue de presse (18 août 2012)

#415
From: SMW
Date: Sat, 18 Aug 2012 18:51
102 lines
5873 bytes
Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press Review (August 18, 2012) – Revue de presse (18 août 2012)


An Aspirin a Day May Still Lower Cancer Risk, but Not as Much as
Previously Thought
A new study offers fresh evidence that popping a daily aspirin is
associated with a lower risk of dying from cancer, but the size of the
potential protective effect may be smaller than previous research has
suggested
By Alexandra Sifferlin. In TIME
http://healthland.time.com/2012/08/10/an-aspirin-a-day-may-still-lower-cancer-risk-but-not-as-much-as-previously-thought/

Radiation after lumpectomy helps prevent need for mastectomy in early
stage breast cancer‎‎
Contrary to clinical recommendations, older women with early stage
breast cancer may want to undergo radiation after lumpectomy to help
ensure that they will not need a mastectomy in the future. That is the
conclusion of a new study published early online in CANCER, a peer-
reviewed journal of the American Cancer Society. The findings indicate
that current thinking on the risks and benefits of radiation for early
stage breast cancer in older women may be inaccurate.
In Science Codex
http://www.sciencecodex.com/radiation_after_lumpectomy_helps_prevent_need_for_mastectomy_in_early_stage_breast_cancer-96414

Early Breast Cancer in Older Women: Mastectomies Avoidable for Some
A study published in Cancer, the journal of the American Cancer
Society, provides evidence that older women with early-stage breast
cancer who undergo radiation therapy following a lumpectomy are less
likely to require a subsequent mastectomy. This is contrary to current
recommendations that suggest radiation therapy does not play a role in
determining whether an older woman will need a mastectomy following a
lumpectomy for her early-stage breast cancer. The authors suggest the
current recommendations are based on inaccurate thinking of the risks
and benefits of radiation therapy.
By Anna Azvolinsky. In Cancer Network
http://www.cancernetwork.com/breast-cancer/content/article/10165/2096869

Komen's Leadership Changes Are Met With Skepticism‎‎ ‎‎
Leadership changes at the Susan G. Komen Foundation for the Cure six
months after an online uproar over a decision to cut funds for breast
cancer screenings at Planned Parenthood was greeted with skepticism on
Thursday among breast cancer advocates and longtime former
supporters.
By Jennifer Preston. In New York Times (blog)
http://thelede.blogs.nytimes.com/2012/08/09/komens-leadership-changes-are-met-with-skepticism/

Screening Debate Typifies Prostate Cancer Uncertainties‎
Experts differ, leaving men with no easy answers.
By Serena Gordon. In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2012/08/10/screening-debate-typifies-prostate-cancer-uncertainties


La surcharge pondérale favorise (aussi) les seconds cancers‎
Combattre le surpoids permet de réduire le risque de développer une
deuxième tumeur, voire un premier cancer du sein.
Par Anne Jeanblanc. Dans Le Point
http://www.lepoint.fr/chroniqueurs-du-point/anne-jeanblanc/la-surcharge-ponderale-favorise-aussi-les-seconds-cancers-13-08-2012-1495564_57.php

Cancer du sein: médicament de Roche homologué en Suisse‎‎
L'homologation se fonde sur les résultats d'une étude qui a montré que
les patientes ayant reçu le traitement combiné par Perjeta ont vécu en
moyenne six mois de plus sans aggravation de leur tumeur cancéreuse.
Dans 24heures.ch
http://www.24heures.ch/sante/sante/Cancer-du-sein-medicament-de-Roche-homologue-en-Suisse/story/11038063

Un cachet d'aspirine par jour réduit les risques de mourir d'un
cancer‎‎‎ ‎‎
Selon les chercheurs, le risque serait diminué de 16%.
Dans Atlantico.fr
http://www.atlantico.fr/pepites/cachet-aspirine-jour-reduit-risque-cancer-449244.html









Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com
Technical Details
Message-ID: <0df6f412-b2c2-44e4-b20a-e30e968b4c42@l7g2000vby.googlegroups.com>
Path: arc1-ca.pugleaf.net!p10ni98095471pbh.1!nntp.google.com!npeer02.iad.highwinds-media.com!news.highwinds-media.com!feed-me.highwinds-media.com!postnews.google.com!l7g2000vby.googlegroups.com!not-for-mail

Show Full Headers
Complete Article Headers
X-Google-Thread: f5500,eae440e0e2147933,start
X-Google-NewGroupId: yes
X-Google-Attributes: gida254ea4a8d,domainid0,public,usenet
X-Google-Language: ENGLISH,UTF8
Received: by 10.68.136.71 with SMTP id py7mr1442945pbb.4.1345315872792;
        Sat, 18 Aug 2012 11:51:12 -0700 (PDT)
Path: arc1-ca.pugleaf.net!p10ni98095471pbh.1!nntp.google.com!npeer02.iad.highwinds-media.com!news.highwinds-media.com!feed-me.highwinds-media.com!postnews.google.com!l7g2000vby.googlegroups.com!not-for-mail
From: SMW <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press Review (August 18, 2012) – Revue de presse (18 août 2012)
Date: Sat, 18 Aug 2012 11:51:12 -0700 (PDT)
Organization: http://groups.google.com
Lines: 104
Message-ID: <0df6f412-b2c2-44e4-b20a-e30e968b4c42@l7g2000vby.googlegroups.com>
NNTP-Posting-Host: 81.247.105.225
Mime-Version: 1.0
X-Trace: posting.google.com 1345315872 6517 127.0.0.1 (18 Aug 2012 18:51:12 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 18 Aug 2012 18:51:12 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: l7g2000vby.googlegroups.com; posting-host=81.247.105.225; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-HTTP-UserAgent: Mozilla/5.0 (Windows NT 5.1) AppleWebKit/537.1 (KHTML, like
 Gecko) Chrome/21.0.1180.79 Safari/537.1,gzip(gfe)
X-Received-Bytes: 5492
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable